ALEXANDRA C SIMPSON
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology CHARLOTTESVILLE, VA NPI 1447784459
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology VA Amgen Inc. All categories
General Payments — all program years on this page
$1,478.02
- Category: General Payments
- Program years: PY2023–2024
- Record count: 19
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $725.19 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $725.19 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $492.89 | 6 |
| GENZYME CORPORATION | $99.47 | 1 |
| EMD Serono, Inc. | $83.27 | 1 |
| Alexion Pharmaceuticals, Inc. | $49.56 | 1 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1093975866 | Alexion Pharmaceuticals, Inc. | $49.56 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111708988 | Amgen Inc. | $36.40 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111708990 | Amgen Inc. | $30.05 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111708992 | Amgen Inc. | $67.06 | 06/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111708994 | Amgen Inc. | $116.58 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111708996 | Amgen Inc. | $121.40 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111708998 | Amgen Inc. | $121.40 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1120244879 | EMD Serono, Inc. | $83.27 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139941195 | GENZYME CORPORATION | $99.47 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.